Security key
09090D301
BiomX Inc. - Common Stock, $0.0001 par value (PHGE)
CUSIP: 09090D301
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 9,960,646
- Total 13F value
- $7,245,970
- Share change
- +561,587
- SEC-reported price per share
- $0.73
- Number of holders
- 16
- Value change
- +$283,360
- Number of buys
- 5
- Number of sells
- 6
- Shares outstanding
- 1,527,040
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
16
Top holders
10
PHGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Tessera Defense & Homeland Security Inc. SEC filings
Tessera Defense & Homeland Security Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09090D301
Recent filing periods:
Ownership snapshot
Top reported holders of PHGE - BiomX Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
OrbiMed Israel BioFund GP...
Disclosed value leader
OrbiMed Israel BioFund GP...
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5
13F
Highest disclosed value: $5,250,517
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
OrbiMed Israel BioFund GP Limited Partnership has the largest disclosed position value at $5.25M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens OrbiMed Israel BioFund GP Limited Partnership's linked filing trail.
Disclosed position value
Top 5
OrbiMed Israel BioFund GP Limited...
$5.25M
Ugwumba Chidozie
$1.02M
ORBIMED ADVISORS LLC
$1.82M
DEERFIELD MANAGEMENT COMPANY, L.P.
$1.82M
Nantahala Capital Management, LLC
$1.77M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| OrbiMed Israel BioFund GP Limited Partnership |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$5,250,517
13,777,980 shares
mixed-class rows
|
— | 15 May 2024 |
| Ugwumba Chidozie |
3/4/5
Exit Form 4 - former 10% owner
|
—
denominator unverified
|
$1,018,989
2,997,025 shares
|
— | 17 Oct 2022 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$1,823,522
1,787,767 shares
|
— | 30 Sep 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
—
denominator unverified
|
$1,823,362
1,787,610 shares
|
— | 30 Sep 2024 |
| Nantahala Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$1,765,212
1,730,600 shares
|
— | 30 Sep 2024 |
| Ikarian Capital, LLC |
13F
Company
|
—
denominator unverified
|
$910,860
893,000 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
9,960,646
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2025 Across Filers
Q3 2025 holders
16
Q4 2024 holders
16
Holder diff
0
| Investor | Q3 2025 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend